Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Bimatoprost may help treat hair loss from alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Inflammatory diets may increase the risk and severity of alopecia areata.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Alopecia areata affects life quality differently based on its severity.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Different thicknesses of hair strands can indicate the severity of hair thinning.

Targeting IL-15 may help treat Alopecia Areata.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Male gender and family history predict alopecia areata recurrence.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Children with alopecia areata in Singapore generally have a good quality of life.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The guideline provides recommendations for managing alopecia areata effectively.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.